Skip to main content
Clinical Trials/IRCT2015092724209N2
IRCT2015092724209N2
Completed
Phase 3

Investigating the effectiveness of methylphenidate and multi chain polyunsaturated fatty acids in treatment of symptoms of attention deficit hyperactivity disorder (ADHD) among 6 to 12 children suffered from ADHD

Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Attention deficit hyperactivity disorder (ADHD).
Sponsor
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser

Eligibility Criteria

Inclusion Criteria

  • Aged 6 to 12 years; diagnosis of attention deficit hyperactivity disorder (ADHD) based on DSM\-IV\-TR diagnostic criteria; the scale to measure attention deficit hyperactivity disorder (ADHD) in parent and teacher form, at least 20\. Exclusion criteria: Any simultaneous major psychiatric disease, except confrontational behavior and learning disorder; IQ less than 70; the use of psychotropic drugs or narcotic materials in the past two weeks; any important neurological diseases; taking any drug affecting the nervous system, at least two weeks prior to the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials